Krystal Biotech Inc (KRYS)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -105.408 | -30.289 | -13.101 | -11.741 | -12.375 | -14.847 | -23.63 | 1.588 |
Return on Equity (%) | -795.848 | -31.831 | -13.385 | -12.076 | -12.997 | -15.71 | -25.089 | 1.681 |
Return on Invested Capital (%) | -107.223 | -18.494 | -14.689 | -14.076 | -13.43 | -16.661 | -27.751 | -18.107 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 25.438 |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 21.563 |
Book Value Per Share | N/A | 4.8 | 7.847 | 11.693 | 14.816 | 23.547 | 18.768 | 25.725 |
Earnings Per Share | N/A | -0.768 | -0.755 | -1.1 | -1.632 | -2.76 | -5.03 | 0.361 |
Cash Per Share | N/A | 4.811 | 7.185 | 10.805 | 13.608 | 13.537 | 5.818 | 11.839 |
Working Capital Per Share | N/A | 4.781 | 7.627 | 11.096 | 13.169 | 16.524 | 12.755 | 18.33 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 1.573 |
EBIT Per Share | N/A | -0.768 | -0.755 | -1.1 | -1.632 | -2.76 | -5.03 | 0.426 |
EBITDA Per Share | N/A | -0.768 | -0.755 | -1.1 | -1.632 | -2.76 | -5.03 | 0.426 |
Free Cash Flow Per Share | N/A | -0.75 | -0.61 | -0.774 | -0.973 | -0.12 | -3.22 | 0.586 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | N/A | 10,31M | 14,43M | 17,35M | 19,71M | 25,21M | 25,76M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 25,76M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | 2.06 | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | 2.06 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 4,59B |
Ratio cours/bénéfice | 412,73 |
Ratio prix/ventes | 88,99 |
Ratio prix/liquidités | 12,59 |
Ratio prix/valeur comptable | 5,79 |
Rendement de dividende | - |
Actions en circulation | 28,76M |
Volume moyen (1 semaine) | 202,8k |
Volume moyen (1 mois) | 294,92k |
Variation sur 52 semaines | 31,91% |
Plus haut sur 52 semaines | 219,34 |
Plus bas sur 52 semaines | 107,50 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales